PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Mar-2022 Mednow Enters Into Agreement to Acquire Mednow East Inc. in Ontario Businesswire
07-Mar-2022 ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022 Businesswire
07-Mar-2022 Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Significant Improvement in Distant Metastasis-Free Survival (DMFS) Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB and IIC Melanoma in Phase 3 KEYNOTE-716 Trial Businesswire
07-Mar-2022 Merck to Hold Investor Event to Highlight Growing Cardiovascular Portfolio and Pipeline Businesswire
07-Mar-2022 KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial Businesswire
07-Mar-2022 Outlook on the Breast Cancer Drug Global Market to 2026 - Increasing Collaboration and Partnership Among Drug Manufacturing Companies Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Mar-2022 Vantage Specialty Chemicals Acquires JEEN Businesswire
07-Mar-2022 India Microelectromechanical Systems (MEMS) Markets, Forecast & Opportunities, FY2027 - ResearchAndMarkets.com Businesswire
07-Mar-2022 Orbit Discovery and WuXi AppTec Sign Agreement to Access Peptide Discovery and Optimisation Technologies Businesswire
07-Mar-2022 The Global Wearable Injectors Market Will Grow to $19,518.9 Million by 2030, at a CAGR of 15.3% - ResearchAndMarkets.com Businesswire
07-Mar-2022 Veristat Expands its Expertise and Scale across Biopharma and Medtech Businesswire
07-Mar-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Mar-2022 SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program Businesswire
07-Mar-2022 One Equity Partners Completes Acquisition of Norit Activated Carbon Businesswire
05-Mar-2022 Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022 SMi Group
04-Mar-2022 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Businesswire
04-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Celsius Holdings, Inc. (CELH) on Behalf of Investors Businesswire
04-Mar-2022 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
04-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of TTEC Holdings, Inc. (TTEC) on Behalf of Investors Businesswire
04-Mar-2022 bluebird bio Reports Fourth Quarter and Full Year 2021 Financial Results, Highlights Operational Progress and Provides Corporate Update Businesswire